The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (NASDAQ: TOI) is a leader in value-based oncology, delivering highly specialized cancer care in the community setting. The company provides cutting-edge, evidence-based treatments to over 1.9 million patients through a network of more than 100 clinics. TOI integrates precision medicine, clinical trials, and compassionate support to improve long-term health outcomes and patient experiences.